Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nemes, Laszlo"'
Autor:
Giangrande P; Department of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Abdul Karim F; National Blood Centre, Kuala Lumpur, Malaysia., Nemes L; National Hemophilia Center and Hemostasis Department, Medical Center of the Hungarian Defence Forces, Budapest, Hungary., You CW; Pediatric Department, Eulji University Hospital, Daejeon, Korea., Landorph A; Novo Nordisk A/S, Søborg, Denmark., Geybels MS; Novo Nordisk A/S, Søborg, Denmark., Curry N; Oxford Haemophilia and Thrombosis Centre and Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Sep; Vol. 18 Suppl 1, pp. 5-14.
Autor:
Giangrande P; Paul Giangrande, Oxford Haemophilia & Thrombosis Centre, Churchill Hospital, Headington, Oxford OX3 7LE, UK, Tel.: +44 1865 225300, Fax: +44 1865 225608, E-mail: paul.giangrande@ndm.ox.ac.uk., Andreeva T, Chowdary P, Ehrenforth S, Hanabusa H, Leebeek FW, Lentz SR, Nemes L, Poulsen LH, Santagostino E, You CW, Clausen WH, Jönsson PG, Oldenburg J
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2017 Jan 26; Vol. 117 (2), pp. 252-261. Date of Electronic Publication: 2016 Dec 01.
Autor:
Batorova, Angelika, Boban, Ana, Brinza, Melen, Lissitchkov, Toshiko, Nemes, Laszlo, Preložnik Zupan, Irena, Smejkal, Petr, Zozulya, Nadezhda, Windyga, Jerzy
The next frontier in hemophilia A management has arrived. However, questions remain regarding the broader applicability of new and emerging hemophilia A therapies, such as the long-term safety and efficacy of non-factor therapies and optimal regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ebbba5bad91d3d0d107008bdba40f75
https://doi.org/10.25122/jml-2022-0103
https://doi.org/10.25122/jml-2022-0103